Marc F. Hansen, PhDProfessor of Medicine, Genetics and Genome Sciences
|
Degree | Institution | Major |
---|---|---|
BA | Macalester College | Biology/Chemistry |
MS | University of Wisconsin | Bacteriology |
PhD | University of Cincinnati College of Medicine | Molecular Genetics |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Ludwig Institute for Cancer Research | Characterization of tumor suppressor genes in human cancer |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Excellence in Mentorship | Glastonbury High School |
Elected Member | Connecticut Academy of Science and Engineering |
Elected Member | Association for Osteobiology |
John G. Haddad Jr. Annual Research Award | Paget Foundation |
Outstanding Faculty Award | Univ. Texas/Houston |
Predoctoral Fellowship | The Albert J. Ryan Foundation |
Predoctoral Traineeship in Molecular Genetics | NIH |
Biology Honors | Macalester College |
William R. Angell Award for Outstanding Biology Student | Macalester College |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
SoM Academic Merit Executive Committee | Advisory Committee | Member | UConn Health | University | 2023 | 2024 |
NCI ZCA1 RTRB-R (O1) S Transition Career Development Award and Institutional Research Training Grants Review Committee | Study Section | Member | External | National | 2023 | 2023 |
NCI ZCA1 RTRB-R (J1) S Transition Career Development Award and Institutional Research Training Grants Review Committee | Study Section | Vice Chair | External | National | 2023 | 2023 |
NCI SEP ZCA1 PCRB-A (A1) S LRP OD-09-108 Clinical Research Loan Repayment Program Review Committee | Study Section | Member | External | National | 2023 | 2023 |
NCI ZCA1 RTRB-R (O1) Transition Career Development Award (K22) Review Committee | Study Section | Member | External | National | 2022 | 2022 |
NCI ZCA1 RTRB-R (M1) Transition Career Development Award (K22) Review Committee | Study Section | Member | External | National | 2022 | 2022 |
SoM Oversight Committee | Advisory Committee | Chair | UConn Health | University | 2022 | 2024 |
UConn Health Board of Directors Academic Affairs Subcommittee | Advisory Committee | Member | UConn Health | University | 2022 | 2024 |
CDMRP Rare Cancer Research Program Concept Sarcoma Peer Review Panel | Study Section | Member | External | National | 2021 | 2021 |
CDMRP RCRP Sarcoma Peer Review Panel | Study Section | Chair | External | National | 2021 | 2021 |
NCI 2020/05 NCI-F Subcommittee F - Institutional Training and Education | Study Section | Member | External | National | 2020 | 2020 |
NCI SEP-5: NCI Clinical and Translational R21 and Omnibus R03 Peer Review Committee | Study Section | Member | External | National | 2020 | 2020 |
NCI 2020/05 NCI-F Subcommittee F - Institutional Training and Education | Study Section | Member | External | National | 2020 | 2020 |
NCI SEP-5: NCI Clinical and Translational R21 and Omnibus R03 Peer Review Committee | Study Section | Member | External | National | 2020 | 2020 |
CDMRP Peer Review Cancer Research Review Committee | Study Section | Member | External | National | 2019 | 2019 |
NICHD ZRG1 SBIB-N (52) Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) Review Committee | Study Section | Member | External | National | 2019 | 2019 |
Austrian Academy of Sciences Doctoral Fellowship Programme Review Committee | Study Section | Member | External | International | 2019 | 2019 |
NCATS ZTR1 RD-8 (01) 1 Rare Disease Clinical Research (U54) Review Committee | Study Section | Member | External | National | 2019 | 2019 |
NCI ZCA1 RPRB-Z (J2) S UH2/UH3 Review Committee | Study Section | Member | External | National | 2018 | 2018 |
CDMRP BCRP EPI Epidemiology Review Committee | Study Section | Member | External | National | 2018 | 2018 |
CDMRP BCRP MBG-2 Molecular Biology and Genetics - 2 Review Committee | Study Section | Member | External | National | 2018 | 2018 |
NCI ZCA1 RPRB-Z (O3) S Multi-Site R01 Review Committee | Study Section | Member | External | National | 2018 | 2018 |
NCI ZCA1 SRB-X (O1) S - Omnibus SEP-6 (R21/R03) Review Committee | Study Section | Chair | External | National | 2018 | 2018 |
NCI ZCA1 TCRB-V (M2) S - Omnibus SEP-6 (R21/R03) Review Committee | Study Section | Co-chair | External | National | 2018 | 2018 |
CDMRP BCRP MBG-2 Molecular Biology and Genetics - 2 Review Committee | Study Section | Member | External | National | 2018 | 2018 |
CDMRP PRCRP Cancer in Children, Adolescents and Young Adults Review Committee | Study Section | Member | External | National | 2017 | 2017 |
NCI ZCA1 SRB-X (J1) Innovative Molecular Analysis Technologies and Biospecimen Review Committee | Study Section | Chair | External | National | 2017 | 2017 |
NCI ZCA1 TCRB-Q (M3) R Innovative Molecular Analysis Technologies (IMAT) R21 Review Committee | Study Section | Chair | External | National | 2017 | 2017 |
NCI ZCA1 TCRB-Q (M4) R Innovative Molecular Analysis Technologies (IMAT) R33 Review | Study Section | Chair | External | National | 2017 | 2017 |
NCI ZCA1 SRB-2 (M1) Cancer Target Discovery and Development Network (U01) Review Committee | Study Section | Vice Chair | External | National | 2017 | 2017 |
NCI ZCA1 RTRB-Z (O1) P NCI Program Project II Review Committee | Study Section | Member | External | National | 2016 | 2016 |
NCI ZCA1 TCRB-D (O1) R Innovative Molecular Analysis Technologies (IMAT) Review Committee | Study Section | Chair | External | National | 2016 | 2016 |
NCI Subcommittee A, 2 P30 CA046934-29 University of Colorado Cancer Center Site Visit | Study Section | Member | External | National | 2016 | 2016 |
NCI ZCA1 TCRB-Q (M3) NCI Omnibus R03 and R21 SEP-13 Review Committee | Study Section | Chair | External | National | 2016 | 2016 |
NCI ZCA1 TCRB-Y (M1) S - Physical Sciences- Oncology Projects Review Committee | Study Section | Chair | External | National | 2016 | 2016 |
NCI ZCA1 TCRB-6 (M3) R - Innovative Molecular Analysis Technologies for Cancer Research Review Committee | Study Section | Chair | External | National | 2016 | 2016 |
NCI ZCA1 TCRB-9 (M1) S - Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research Review Committee | Study Section | Chair | External | National | 2016 | 2016 |
NCI Subcommittee A, 2 P30 CA013148-44 University of Alabama, Birmingham Site Visit | Study Section | Member | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-Q (O2) R – Advanced Development of Technologies for Cancer Research Review Committee | Study Section | Co-chair | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-6 (A1) B – Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3) Review Committee | Study Section | Vice Chair | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-9 (O1) R - Innovative Research in Cancer Nanotechnology (IRCN) (U01) Review Committee | Study Section | Chair | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-T (O1) – Physical Sciences Oncology Center (U54) Review Committee | Study Section | Member | External | National | 2015 | 2015 |
NCI ZCA1 SRB-V (O1) S – NCI Exploratory/Development Research Grant Program Omnibus SEP-3 Review Committee | Study Section | Chair | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-Q (M1) R - Centers of Cancer Nanotechnology Excellence (CCNE) Review Committee | Study Section | Chair | External | National | 2015 | 2015 |
NCI ZCA1 SRB-V (M1) S - NCI Small Grants Program and Exploratory/Developmental Research Grant Program on Cancer Biology-3 (Omnibus R03/R21) Review Committee | Study Section | Chair | External | National | 2015 | 2015 |
NCI ZCA1 TCRB-5 (M1) R - Innovative Molecular Analysis Technologies Review Committee | Study Section | Member | External | National | 2015 | 2015 |
NCI ZCA1 GRB-P (J1) R - NCI Director’s Provocative Questions B Review Committee | Study Section | Chair | External | National | 2014 | 2014 |
NCI Subcommittee A, 2 P30 CA042014-26 Univ. Utah Huntsman Cancer Center Site Visit | Study Section | Member | External | National | 2014 | 2014 |
Experiment to Evaluate the Relative Quality of Applications Reviewed in Chartered Study Sections: Oncology 1 – Basic Translational (OBT) Integrated Review Group | Study Section | Member | External | National | 2014 | 2014 |
KCALSI Patton Trust Review Committee | Study Section | Member | External | National | 2014 | 2014 |
NCI ZCA1 TCRB-Q (O2) S – Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Review Committee | Study Section | Chair | External | National | 2014 | 2014 |
NCI ZCA1 SRB-V (O1) R – NCI Small Grants Program and Exploratory/Developmental Research Grant Program for Cancer Research (Omnibus R03/R21) Review Committee | Study Section | Chair | External | National | 2014 | 2014 |
NCI ZCA1 SRLB-R (M1) R – Cancer Detection, Diagnosis, and Treatment Technologies for Global Health Review Committee | Study Section | Member | External | National | 2014 | 2014 |
NCI ZCA1 SRLB-V (M1) R - NCI Small Grants Program and Exploratory/Developmental Research Grant Program on Cancer Biology-3 (Omnibus R03/R21) Review Committee | Study Section | Chair | External | National | 2014 | 2014 |
CDMRP Peer Reviewed Cancer Research Program Review Committee | Study Section | Member | External | National | 2014 | 2014 |
NCI ZCA1 GRB-P(A1) R – NCI Director’s Provocative Questions A and C Review Committee | Study Section | Chair | External | National | 2014 | 2014 |
Syracuse University Doctoral Program in Forensic and Regulatory Science Review Committee | Study Section | Co-chair | External | Regional | 2014 | 2014 |
Meta Gene | Professional/Scientific Journal | Executive Editor | External | National | 2013 | 2014 |
NCI ZCA1 SRLB-Q (M1) R – Validation and Advanced Development of Emerging Technologies for Cancer Research | Professional/Scientific Organization | Vice Chair | External | National | 2013 | 2013 |
NCI SRLB-X (M1) R – Omnibus R03/R21: Developmental Therapeutics | Professional/Scientific Organization | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 RTRB-Z (M1) R – Omnibus R03/R21: Therapeutics | Professional/Scientific Organization | Member | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-R (M1) R – Cancer Prevention Research Small Grant Program | Professional/Scientific Organization | Member | External | National | 2013 | 2013 |
NIH ZRG1 MOSS-B (02) M - Salivary Glands, Oral Microbiology and Oral Pathology | Professional/Scientific Organization | Member | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-X (Q1) R – Nanotechnology in Cancer | Professional/Scientific Organization | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 RTRB-E (O1) R - Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) | Professional/Scientific Organization | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 RTRB-Z (O2) M – Special Emphasis Panel for T32 Application Review | Professional/Scientific Organization | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-4 (J1) S - Omnibus Grants on Cancer Genetics and Etiology | Professional/Scientific Organization | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-R (J1) R - NCI Director’s Provocative Questions | Professional/Scientific Organization | Member | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-X (J1) R – Nanotechnology-Based Theranostics Review Committee | Study Section | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-R (J1) R - NCI Director’s Provocative Questions (R21) Review Committee | Study Section | Vice Chair | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-Q (J2) R - Advance Development and Validation of Emerging Technologies for Cancer Research (R33) Review Committee | Study Section | Chairman | External | National | 2013 | 2013 |
NCI ZCA1 SRLB-X (J3) R – NCI Omnibus – Drug and Gene Delivery Review Committee | Study Section | Chairman | External | National | 2013 | 2013 |
University of Connecticut Health Center: MSI Research Day Organizing Committee | Professional/Scientific Organization | Member | UConn Health | University | 2012 | 2012 |
University of Connecticut Health Center: Hearing Committee for Misconduct in Research | Professional/Scientific Organization | Member | UConn Health | University | 2012 | 2012 |
University of Connecticut Health Center: | Professional/Scientific Organization | Member | UConn Health | University | 2012 | |
NCI SEP ZCA1 SRLB-9 (M1) R - Provocative Questions R01 | Professional/Scientific Organization | Co-Chair | External | National | 2012 | 2012 |
NCI ZCA1 SRLB-D (M1) R - Provocative Questions R21 | Professional/Scientific Organization | Member | External | National | 2012 | 2012 |
NCI ZCA1 SRLB-4 (O1) R - Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) | Professional/Scientific Organization | Chairman | External | National | 2012 | 2012 |
NCI ZCA1 SRLB-V (J2) R – Cancer Detection | Professional/Scientific Organization | Chairman | External | National | 2012 | 2012 |
NCI ZCA1 SRLB-4 (J1) B - Strategic Partnering to Evaluate Cancer Signatures II | Professional/Scientific Organization | Chairman | External | National | 2012 | 2012 |
Nanomedicine: Nanotechnology, Biology, and Medicine | Professional/Scientific Journal | Associate Editor | External | National | 2011 | 2015 |
Gene | Professional/Scientific Journal | Board of Editors and Associate Editor | External | National | 2011 | 2019 |
NCI SEP ZCA1 SRLB-9 (M1) R - In vivo Cellular and Molecular Imaging Centers | Professional/Scientific Organization | Vice Chair | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-V (M1) R – Emerging Technologies for Cancer Research | Professional/Scientific Organization | Chairman | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-5 (O1) R - Innovative Emerging Molecular Analysis Technologies | Professional/Scientific Organization | Member | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-9 (O1) B - Advanced in Vivo Imaging to Understand Cancer Systems | Professional/Scientific Organization | Vice-Chair | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-X (O1) R - Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology | Professional/Scientific Organization | Chairman | External | National | 2011 | |
USAMRMC Peer Reviewed Medical Research Program:Paget’s Disease Review Committee | Professional/Scientific Organization | Member | External | National | 2011 | 2011 |
USAMRMC PRMRP: Osteoporosis and Related Bone Disease Panel 2 Review Committee | Professional/Scientific Organization | Member | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-4 (J1) S - Strategic Partnering to Evaluate Cancer Signatures | Professional/Scientific Organization | Member | External | National | 2011 | 2011 |
NCI SEP ZCA1 SRLB-V (j1) R – Cancer Target Discovery and Development | Professional/Scientific Organization | Member | External | National | 2011 | 2011 |
University of Connecticut Health Center: Search Committee, Chairman of Cell Biology | Professional/Scientific Organization | Member | UConn Health | University | 2010 | 2011 |
University of Connecticut Health Center: PhD Admissions Review Committee | Professional/Scientific Organization | Member | UConn Health | University | 2010 | |
NCI SEP ZCA1 SRLB-9 (M1) R In vivo Cellular and Molecular Imaging Centers (ICMICs) | Professional/Scientific Organization | Chairman | External | National | 2010 | 2010 |
NCI SEP ZCA1 SRLB-R (M1) R Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) | Professional/Scientific Organization | Chairman | External | National | 2010 | 2010 |
NIH SEP ZRG1 MOSS-G (55) R RFA-OD-10-005 Director's Opportunity 5 Themes Oral Musculoskeletal and Imaging | Professional/Scientific Organization | Member | External | National | 2010 | 2010 |
NCI SEP ZCA1 RTRB-Z (M2) R Special Emphasis Panel | Professional/Scientific Organization | Member | External | National | 2010 | 2010 |
NCI SEP ZCA1 SRLB-R (O1) – Emerging Technologies for Cancer Research | Professional/Scientific Organization | Chairman | External | National | 2010 | 2010 |
NCI SEP ZCA1 SRLB-X (J1) R – Emerging Technologies for Cancer Research | Professional/Scientific Organization | Chairman | External | National | 2010 | 2010 |
NCI SEP ZCA1 SRLB-4 (J1) B ¬– Strategic Partnering to Evaluate Cancer Signatures | Professional/Scientific Organization | Chairman | External | National | 2010 | 2010 |
Comitato Telethon Fondazione Onlus E Fondazione Telethon Grant Review Panel | Professional/Scientific Organization | Member | External | National | 2010 | 2011 |
USAMRMC Breast Cancer Research Program TRN CBY-A Peer Review Committee | Professional/Scientific Organization | Member | External | National | 2009 | 2009 |
NCI SEP ZCA1 PCRB-A (A1) S LRP OD-09-108 Clinical Research Loan Repayment Program | Professional/Scientific Organization | Member | External | National | 2009 | |
National Cancer Institute SEP ZCA1 SRLB-V (M1) Application of Emerging Technologies | Professional/Scientific Organization | Chairman | External | National | 2009 | 2009 |
National Cancer Institute SEP ZCA1 SRLB-9 (O1) Physical Sciences-Oncology Centers | Professional/Scientific Organization | Co-Chairman | External | National | 2009 | 2009 |
National Institutes of Health SEP ZRG1 MOSS-A (96) S Skeletal Biology II ARRA CR | Professional/Scientific Organization | Member | External | National | 2009 | 2009 |
National Institutes of Health SEP ZRG1 MOSS-C (58) R RFA OD-09-003: Challenge Grants | Professional/Scientific Organization | Member | External | National | 2009 | 2009 |
NCI SEP ZCA1 PCRB-G (O9) R NCI-ARRA P30 Biomedical Research Core Centers Review | Professional/Scientific Organization | Member | External | National | 2009 | 2009 |
National Cancer Institute SEP ZCA1 SRLB-4 (O2) R Bio-specimen Preparation | Professional/Scientific Organization | Chairman | External | National | 2009 | 2009 |
NCI SEP ZCA1 SRLB-4 (O9) R Grand Opportunities Grants in Human Cancer Proteomics | Professional/Scientific Organization | Chairman | External | National | 2009 | 2009 |
Howard Hughes Medical Institute Med Into Grad Review Panel | Professional/Scientific Organization | Member | External | State | 2009 | 2009 |
NCI SEP ZCA1 SRLB-U (O9) R NCI ARRA GO - Transcriptional & Translational | Professional/Scientific Organization | Chairman | External | National | 2009 | 2009 |
National Institutes of Health SEP ZRG1 CBSS-P (08) F - Tumor Biomarkers | Professional/Scientific Organization | Member | External | National | 2009 | 2009 |
NCI SEP ZCA1 SRLB-V (J1) R Applied Emerging Technologies in Biospecimen Science | Professional/Scientific Organization | Chairman | External | National | 2009 | 2009 |
National Cancer Institute SEP ZCA1 GRB-S (M1) P Molecular Oncology | Professional/Scientific Organization | Member | External | National | 2008 | 2008 |
National Institute of Arthritis, Musculoskeletal and Skin Diseases SEP ZAR1 MLB-G (M2) | Professional/Scientific Organization | Member | External | National | 2008 | 2008 |
National Cancer Institute SEP ZCA1 SRRB-4 (M1) Application of Emerging Technologies | Professional/Scientific Organization | Chairman | External | National | 2008 | 2008 |
National Institutes of Health SEP ZRG1 MOSS-L (04) Skeletal Biology/Disease | Professional/Scientific Organization | Member | External | National | 2008 | 2008 |
National Cancer Institute SEP ZCA1 SRRB-4 (01) Application of Emerging Technologies | Professional/Scientific Organization | Chairman | External | National | 2008 | 2008 |
National Center for Research Resources SEP ZRR1 RI-4 (01) INBRE Awards | Professional/Scientific Organization | Member | External | National | 2008 | 2008 |
National Cancer Institute SEP ZCA1 SRRB-4 (J1) Application of Emerging Technologies | Professional/Scientific Organization | Chairman | External | National | 2008 | 2008 |
University of Connecticut Health Center: Translational Genomic Core Facility Advisory Committee | Professional/Scientific Organization | Member | UConn Health | University | 2007 | |
University of Connecticut Health Center: Health Center Appeals Committee | Professional/Scientific Organization | Member | UConn Health | University | 2007 | 2007 |
National Cancer Institute SEP ZCA1 GRB-S (M1) Molecular Biology PPG SEP | Professional/Scientific Organization | Member | External | National | 2007 | 2007 |
National Cancer Institute SEP ZCA1 SRRB-4 (M1) Application of Emerging Technologies | Professional/Scientific Organization | Member | External | National | 2007 | 2007 |
National Institutes of Health SEP ZRG1 MOSS-B (02) Skeletal Biology/Disease | Professional/Scientific Organization | Member | External | National | 2007 | 2007 |
USAMRMC Prostate Cancer Research Program MBG-2 Peer Review Committee | Professional/Scientific Organization | Member | External | National | 2007 | 2010 |
University of Connecticut Health Center: Intercampus Interdisciplinary Oncology Program Steering Committee | Professional/Scientific Organization | Member | UConn Health | University | 2006 | 2007 |
University of Connecticut Health Center: ACS Institutional Research Award Review Committee | Professional/Scientific Organization | Member | UConn Health | University | 2006 | |
National Institutes of Health SEP ZRG1 MOSS-B Skeletal Biology/Disease | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Cancer Institute SEP ZCA1 SRRB-9 (M1) for NCI RFA CA-06-003 | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Cancer Institute SEP ZCA1 RPRB-O (O2) Cellular and Tissue Biology | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Cancer Institute SEP ZCA1 SRBB-4 (O1) Application of Emerging Technologies | Professional/Scientific Organization | Chairman | External | National | 2006 | 2006 |
National Cancer Institute SEP ZCA1 SRRB-9 (O1) for NCI RFA CA-07-005 | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Cancer Institute IRG Subcommittee I on Career Development | Professional/Scientific Organization | Member | External | National | 2006 | |
National Cancer Institute Ad Hoc Review Committee for K99/R00 Awards | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Institute of Biomedical Imaging and Bioengineering SEP ZEB1 OSR-A (J1) | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
National Cancer Institute SEP ZCA1 RTRB-Z (J1) Transition Career Development Award | Professional/Scientific Organization | Member | External | National | 2006 | 2006 |
ASBMR State-of-the-Art Lecture: Cancer and Bone Basic/Translational | Professional/Scientific Organization | Co-chair | External | National | 2006 | |
Connecticut Academy of Science and Engineering | Professional/Scientific Organization | Member | External | State | 2005 | |
University of Connecticut Health Center: Neag Comprehensive Cancer Center Steering Committee | Professional/Scientific Organization | Member | UConn Health | University | 2005 | 2007 |
University of Connecticut Health Center: Musculoskeletal Oncology Program, Neag Comprehensive Cancer Center | Professional/Scientific Organization | Director | UConn Health | University | 2005 | 2007 |
University of Connecticut Health Center: Head & Neck Oncology Program, Neag Comprehensive Cancer Center | Professional/Scientific Organization | Deputy Director | UConn Health | University | 2005 | 2007 |
American Cancer Society Council for Extramural Grants | Professional/Scientific Organization | Member | External | National | 2005 | 2009 |
James & Esther King Biomedical Research Program Review Committee | Professional/Scientific Organization | Member | External | National | 2005 | |
National Institutes of Health Cancer Genetics Study Section | Professional/Scientific Organization | Member | External | National | 2004 | 2009 |
National Institutes of Health SEP ZRG1 RUS-D(05) Endocrinology/Biology of Bone | Professional/Scientific Organization | Member | External | National | 2004 | 2004 |
National Institutes of Health SEP ZRG1 GNM(91) ATM Biology | Professional/Scientific Organization | Member | External | National | 2004 | 2004 |
American Cancer Society Lymphedema Research Committee | Professional/Scientific Organization | Member | External | National | 2004 | 2007 |
National Cancer Institute Ad Hoc Review Committee for NCI RFA CA-04-015 | Professional/Scientific Organization | Member | External | National | 2004 | 2004 |
Association of Osteobiology | Professional/Scientific Organization | Member | External | National | 2003 | |
Florida Biomedical Research Grant Program Study Section | Professional/Scientific Organization | Member | External | State | 2003 | 2003 |
American Cancer Society Research Opportunity Grants Program Review Committee | Professional/Scientific Organization | Member | External | National | 2003 | 2003 |
USAMRMC Breast Cancer Research Program Concept Award Review Committee | Professional/Scientific Organization | Member | External | National | 2003 | 2003 |
National Cancer Institute SRBB-Y (A1), Clinical/Pediatric Loan Repayment program | Professional/Scientific Organization | Member | External | National | 2003 | 2009 |
National Cancer Institute IRG Subcommittee I on Career Development | Professional/Scientific Organization | Member | External | National | 2003 | 2005 |
National Institutes of Health SEP ZRG1 ONC (02), Molecular Targets/Cancer Drugs | Professional/Scientific Organization | Member | External | National | 2003 | 2003 |
National Institutes of Health SEP ZRG1 GRM(03) Musculoskeletal Dental SEP | Professional/Scientific Organization | Member | External | National | 2003 | 2003 |
USAMRMC Breast Cancer Research Program CBY2 Peer Review Committee | Professional/Scientific Organization | Member | External | National | 2003 | 2003 |
NIAMS Site Visit Study Section for Program Project AR049363-01A1 | Professional/Scientific Organization | Chairman | External | National | 2003 | 2003 |
National Institutes of Health Skeletal Biology Development/Disease Study Section | Professional/Scientific Organization | Member | External | National | 2003 | 2011 |
University of Connecticut Health Center: LCME Self-Assessment Committee | Professional/Scientific Organization | Member | UConn Health | University | 2002 | 2003 |
University of Connecticut Health Center: Health Center Space Advisory Committee | Professional/Scientific Organization | Chair | UConn Health | University | 2002 | 2006 |
American Cancer Society Molecular Genetics and Oncogenes Committee | Professional/Scientific Organization | Chairman | External | National | 2002 | 2002 |
NIAMS Site Visit Study Section for Program Project AR049363-01 | Professional/Scientific Organization | Chairman | External | National | 2002 | 2002 |
USAMRMC Breast Cancer Research Program CBY4 Peer Review Committee | Professional/Scientific Organization | Member | External | National | 2002 | 2002 |
Physiological Medicine Review Panel for Medical Research Council (UK) | Professional/Scientific Organization | Member | External | National | 2002 | 2002 |
University of Connecticut Health Center: Ad hoc Curriculum Committee on Genetics | Professional/Scientific Organization | Member | UConn Health | University | 2001 | |
University of Connecticut Health Center: Health Center Research Advisory Committee | Professional/Scientific Organization | Member | UConn Health | University | 2001 | 2005 |
University of Connecticut Health Center: GMBB Graduate Program Executive Board | Professional/Scientific Organization | Member | UConn Health | University | 2001 | 2003 |
American Cancer Society Molecular Genetics and Oncogenes Committee | Professional/Scientific Organization | Member | External | National | 2001 | 2001 |
National Cancer Institute IRG Subcommittee F on Manpower and Training | Professional/Scientific Organization | Member | External | National | 2001 | 2003 |
University of Connecticut Health Center: Computer Users Advisory Committee | Professional/Scientific Organization | Member | UConn Health | University | 2000 | 2007 |
University of Connecticut Health Center: Molecular Core Advisory Committee | Professional/Scientific Organization | Member | UConn Health | University | 2000 | |
University of Connecticut Health Center: Microarray Core Advisory Committee | Professional/Scientific Organization | Member | UConn Health | University | 2000 | 2012 |
University of Connecticut Health Center: Special Review Board for Misconduct in Research | Professional/Scientific Organization | Member | UConn Health | University | 2000 | 2001 |
American Cancer Society Experts Directory | Professional/Scientific Organization | Member | External | National | 2000 | |
American Society for Bone and Mineral Research | Professional/Scientific Organization | Member | External | National | 1999 | |
National Institute of Dental and Craniofacial Research Ad Hoc Review Committee | Professional/Scientific Organization | Member | External | National | 1999 | 1999 |
National Institutes of Health Molecular Biology Study Section Committee | Professional/Scientific Organization | Member | External | National | 1999 | 1999 |
National Cancer Institute Ad Hoc Review Committee for NCI RFA CA-98-027 | Professional/Scientific Organization | Member | External | National | 1999 | 1999 |
National Cancer Institute IRG Subcommittee C on Basic and Pre-clinical Trials | Professional/Scientific Organization | Member | External | National | 1999 | 2007 |
National Cancer Institute IRG Subcommittee D on Clinical Studies | Professional/Scientific Organization | Member | External | National | 1999 | 2007 |
Intergroup Therapeutic Study P-9851: Osteosarcoma Biology Protocol | Professional/Scientific Organization | Member | External | National | 1999 | |
Temple Univ. School of Medicine: Molecular Biology Graduate Program | Professional/Scientific Organization | Director | External | University | 1998 | 1999 |
National Cancer Institute IRG Subcommittee A on Cancer Centers | Professional/Scientific Organization | Member | External | National | 1998 | |
National Institutes of Health Mammalian Genetics: Study Section Committee | Professional/Scientific Organization | Member | External | National | 1998 | 1998 |
National Cancer Institute IRG Subcommittee F on Manpower and Training | Professional/Scientific Organization | Member | External | National | 1998 | 2001 |
Temple Univ. School of Medicine: Molecular Biology Graduate Program | Professional/Scientific Organization | Co-Director | External | University | 1997 | 1998 |
Temple Univ. School of Medicine: Molecular Biology Graduate Student Curriculum Committee | Professional/Scientific Organization | Member | External | University | 1997 | 1999 |
Temple Univ. School of Medicine: Molecular Biology Graduate Student Admissions Committee | Professional/Scientific Organization | Member | External | University | 1997 | 1999 |
American Cancer Society Molecular Genetics and Oncogenes Committee | Professional/Scientific Organization | Member | External | National | 1997 | 2002 |
BioTechniques | Professional/Scientific Journal | Board of Editors | External | National | 1996 | 2000 |
Temple Univ. School of Medicine: Department of Pathology Graduate Program Committee | Professional/Scientific Organization | Member | External | University | 1996 | 1999 |
USAMRMC Breast Cancer Research Program MGN3 Peer Review Committee | Professional/Scientific Organization | Member | External | National | 1996 | 2001 |
National Institutes of Health Genome Study Section Committee | Professional/Scientific Organization | Member | External | National | 1995 | |
Childrens Cancer Group Bone Tumor Strategy Committee | Professional/Scientific Organization | Member | External | National | 1994 | 1994 |
Univ. TX MD Anderson Cancer Center: Academic Computing Steering Committee | Professional/Scientific Organization | Member | External | University | 1992 | 1994 |
Univ. TX MD Anderson Cancer Center: Intellectual Property Committee | Professional/Scientific Organization | Member | External | University | 1992 | 1994 |
Univ. TX Graduate School of Biomedical Sciences: Genetics Program Curriculum Committee | Professional/Scientific Organization | Member | External | University | 1992 | 1994 |
American Cancer Society Virology and Molecular Biology Review Board | Professional/Scientific Organization | Member | External | National | 1992 | 1996 |
National Cancer Institute Cancer Center Review Board Site Visit Committees | Professional/Scientific Organization | Member | External | National | 1992 | 1997 |
Childrens Cancer Group Study Protocol B-931 | Professional/Scientific Organization | Chairman | External | National | 1992 | 1998 |
Childrens Cancer Group Genetic Epidemiology Steering Committee | Professional/Scientific Organization | Member | External | National | 1992 | 1994 |
Univ. TX MD Anderson Cancer Center: Executive Vice President's Junior Faculty Forum | Professional/Scientific Organization | Member | External | University | 1991 | 1994 |
Univ. TX MD Anderson Cancer Center: Genetic Counseling Policy Committee | Professional/Scientific Organization | Member | External | University | 1991 | 1994 |
Univ. TX Graduate School of Biomedical Sciences: Graduate Student Admissions Committee | Professional/Scientific Organization | Member | External | University | 1991 | 1994 |
Univ. TX Graduate School of Biomedical Sciences: Genetics Program Steering Committee | Professional/Scientific Organization | Member | External | University | 1991 | 1994 |
National Institute for Environmental Health Sciences Review Committee | Professional/Scientific Organization | Member | External | National | 1990 | 1990 |
National Cancer Institute Program Project Review Board Site Visit Committees | Professional/Scientific Organization | Member | External | National | 1989 | 1999 |
American Society for Microbiology | Professional/Scientific Organization | Member | External | National | 1988 | 1996 |
American Society of Human Genetics | Professional/Scientific Organization | Member | External | National | 1988 | 2002 |
American Association for Cancer Research | Professional/Scientific Organization | Member | External | National | 1988 | |
Childrens Cancer Group/Childrens Oncology Group | Professional/Scientific Organization | Member | External | National | 1988 | |
Canadian Biomedical Research Council Review Panel | Professional/Scientific Organization | Member | External | National | 1988 | 1989 |
American Journal of Human Genetics | Professional/Scientific Journal | Reviewer | External | National | ||
American Journal of Medical Genetics | Professional/Scientific Organization | Reviewer | External | National | ||
American Journal of Pathology | Professional/Scientific Organization | Reviewer | External | National | ||
BioTechniques | Professional/Scientific Organization | Reviewer | External | National | ||
Bone | Professional/Scientific Journal | Reviewer | External | National | ||
Calcified Tissue International | Professional/Scientific Journal | Reviewer | External | National | ||
Cancer | Professional/Scientific Journal | Reviewer | External | National | ||
Cancer Epidemiology & Biomarkers | Professional/Scientific Journal | Reviewer | External | National | ||
Cancer Letters | Professional/Scientific Journal | Reviewer | External | National | ||
Cancer Research | Professional/Scientific Organization | Reviewer | External | National | ||
Clinical Cancer Research | Professional/Scientific Journal | Reviewer | External | National | ||
Cell | Professional/Scientific Journal | Reviewer | External | National | ||
Developmental Biology | Professional/Scientific Journal | Reviewer | External | National | ||
Gene | Professional/Scientific Journal | Reviewer | External | National | ||
Genes and Development | Professional/Scientific Journal | Reviewer | External | National | ||
Genes | Professional/Scientific Journal | Reviewer | External | National | ||
Chromosomes & Cancer | Professional/Scientific Journal | Reviewer | External | National | ||
Genome Research | Professional/Scientific Journal | Reviewer | External | National | ||
Genomics | Professional/Scientific Journal | Reviewer | External | National | ||
Human Genetics | Professional/Scientific Journal | Reviewer | External | National | ||
Human Molecular Genetics | Professional/Scientific Journal | Reviewer | External | National | ||
International Journal of Cancer | Professional/Scientific Journal | Reviewer | External | International | ||
Journal of Cellular Biochemistry | Professional/Scientific Journal | Reviewer | External | National | ||
Journal of Cellular Physiology | Professional/Scientific Journal | Reviewer | External | National | ||
Journal of Experimental Medicine | Professional/Scientific Journal | Reviewer | External | National | ||
Journal of Bone and Mineral Research | Professional/Scientific Journal | Reviewer | External | National | ||
Journal of Molecular Diagnosis | Professional/Scientific Journal | Reviewer | External | National | ||
MetaGene | Professional/Scientific Journal | Reviewer | External | National | ||
Molecular and Cellular Biology | Professional/Scientific Journal | Reviewer | External | National | ||
Molecular Biology Reports | Professional/Scientific Journal | Reviewer | External | National | ||
Molecular Carcinogenesis | Professional/Scientific Journal | Reviewer | External | National | ||
Mutation Research | Professional/Scientific Journal | Reviewer | External | National | ||
Nature | Professional/Scientific Journal | Reviewer | External | National | ||
Nature Genetics | Professional/Scientific Journal | Reviewer | External | National | ||
New England Journal of Medicine | Professional/Scientific Organization | Reviewer | External | National | ||
Oncogene | Professional/Scientific Journal | Reviewer | External | National | ||
PLoS Medicine | Professional/Scientific Journal | Reviewer | External | National | ||
Proceedings of the National Academy of Sciences (USA) | Professional/Scientific Journal | Reviewer | External | National | ||
Science | Professional/Scientific Journal | Reviewer | External | National | ||
NCI ZCA1 RTRB-R (M1) Transition Career Development Award (K22) Review Committee | Study Section | Member | External | National | ||
NCI ZCA1 RTRB-R (O1) Transition Career Development Award (K22) Review Committee | Study Section | Member | External | National | ||
CDMRP Rare Cancer Research Program Peer Review Panel | Study Section | Member | External | National | ||
CDMRP Peer Review Cancer Research Program Peer Review Panel | Study Section | Member | External | National |
Osteosarcoma is the most common primary tumor of bone and represents in important opportunity for interaction between basic and clinical research.
Osteosarcoma is highly variable in its presentation with numerous subtypes based on the histology, age of onset and site of occurrence. We are interested in examining the molecular differences between these subtypes particularly in the context of the osteoprogenitor lineage pathways from which these tumors arose.
The second area of interest in my laboratory is the genetic origins of Paget’s disease of bone. Paget’s disease is a focal disorder of bone remodeling that leads to overgrowth of affected bone, which in rare cases progresses to osteosarcoma. It is the second most common metabolic bone disease after osteoporosis affecting 1-3% of the U.S. population after age 50. Approximately 20% of Paget’s patients have a positive family history for the disease. Although relatively common, the etiology of Paget’s disease has so far eluded researchers. Our data suggests a model in which a subset of cells might be responsible for the pagetic phenotype in the affected bone. My laboratory is interested in learning what genetic events are critical to the initiation and progression of this disease.
We use several approaches to address these problems. Laser capture microdissection combined with allelotype discrimination analysis, high throughput genotype analysis, comparative and arrayed BAC genome hybridization, cDNA microarray and mass spectroscopy analysis allow us to compare genomic and expression profiles. We then validate our analysis using tissue microarrays, quantitative PCR and other high sample throughput methods. Finally, we use in situ hybridization and immunohistochemistry to validate the expression profiles of our candidate genes. We have also begun to develop transgenic mouse models for osteosarcoma to test its relationship with normal bone development.
Not accepting students for Lab Rotations at this time
Journal Articles
-
Comparative transcriptomic analysis identifies distinct molecular signatures and regulatory networks of chondroclasts and osteoclasts.
Arthritis research & therapy 2020 Jul;22(1):168
-
Deletion of Wnt5a in osteoclasts results in bone loss through decreased bone formation.
Annals of the New York Academy of Sciences 2020 Jan;
-
Articular cartilage protection in Ctsk-/- mice is associated with cellular and molecular changes in subchondral bone and cartilage matrix.
Journal of cellular physiology 2018 May;2338666-8676
-
Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma.
International journal of oncology 2017 Mar;50(3):863-872
-
Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.
Bone 2016 Nov;95124-135
-
The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.
Calcified tissue international 2015 Dec;98489-96
-
Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling.
Journal of cellular physiology 2015 Apr;230(12):2951-60
-
Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.
PloS one 2015 Jan;10(9):e0138194
-
Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009 Mar;24(3):484-94
-
Biomarkers in Osteosarcoma.
Expert opinion on medical diagnostics 2009 Jan;3(1):13-23
-
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors.
Oncogene 2007 Mar;26(12):1714-22
-
Osteosarcoma in Paget's disease of bone
Journal of Bone and Mineral Research 2007 Jan;22(SUPPL. 2):
-
Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
Cancer research 2006 Jul;66(13):6657-64
-
Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan;11(1):162-5
-
Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Oct;18(10):1748-53
-
Analysis of environmental factors in familial versus sporadic Paget's disease of bone--the New England Registry for Paget's Disease of Bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Aug;18(8):1519-24
-
Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma.
International journal of cancer. Journal international du cancer 2003 Jun;105(2):285-8
-
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Feb;18(2):376-80
-
An adaptive strategy for single- and multi-cluster gene assignment.
Biotechnology progress 2003 Jan;19(4):1142-8
-
Psychiatric residents' exposure to the field of sleep medicine: a survey of program directors.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2002 Jan;26(4):253-6
-
Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
International journal of cancer. Journal international du cancer 2000 Mar;85(5):654-8
-
Germline mutations of the p53 gene in children with malignant solid tumors.
Journal of experimental & clinical cancer research : CR 1998 Dec;17(4):497-502
-
Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone.
American journal of human genetics 1998 Sep;63(3):817-24
-
A germline missense mutation R337C in exon 10 of the human p53 gene.
Human mutation 1998 Jan;Suppl 1S58-61
-
A splicing mutation in RB1 in low penetrance retinoblastoma.
Human genetics 1997 Oct;100(5-6):557-63
-
Induction of apoptosis in Mv1Lu cells by expression of competitive RB1 mutants.
Oncogene 1997 Aug;15(9):1069-77
-
Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids.
Oncogene 1997 Apr;14(14):1669-78
-
Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies.
American journal of human genetics 1997 Jan;60(1):80-6
-
Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis.
Cancer research 1997 Jan;57(1):106-9
-
SV40-like sequences in human bone tumors.
Oncogene 1996 Aug;13(3):527-35
-
Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.
American journal of human genetics 1995 May;56(5):1125-31
-
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
Cancer research 1995 May;55(9):1963-70
-
The retinoblastoma gene and its significance.
Annals of medicine 1994 Jun;26(3):177-84
-
Identification of a polymorphism in intron 2 of the p53 gene.
Human genetics 1994 May;93(5):607-8
-
Concordance between parental origin of chromosome 13q loss and chromosome 6p duplication in sporadic retinoblastoma.
American journal of human genetics 1994 Feb;54(2):274-81
-
A method to isolate DNA from small archival tissue samples for p53 gene analysis.
Human mutation 1993 Jan;2(2):123-6
-
Molecular genetic considerations in osteosarcoma.
Clinical orthopaedics and related research 1991 Sep;(270):237-46
-
Structural alterations at the putative retinoblastoma locus in some human leukemias and preleukemia.
Cancer genetics and cytogenetics 1990 Oct;49(1):15-23
-
Codon 72 polymorphism of the TP53 gene.
Nucleic acids research 1990 Aug;18(16):4961
-
Loss of genetic information in cancer.
Ciba Foundation symposium 1989 Jan;14279-88; discussion 88-92
-
Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus.
Molecular and cellular biology 1989 Jan;9(1):1-5
-
Clonal genomic alterations in glioma malignancy stages.
Cancer research 1988 Oct;48(19):5546-51
-
Retinoblastoma and the progression of tumor genetics.
Trends in genetics : TIG 1988 May;4(5):125-8
-
Tumor suppressors: recessive mutations that lead to cancer.
Cell 1988 Apr;53(2):173-4
-
Genetics of cancer predisposition.
Cancer research 1987 Nov;47(21):5518-27
-
Retinoblastoma and osteosarcoma: the prototypic cancer family.
Acta paediatrica Japonica; Overseas edition 1987 Aug;29(4):526-33
-
Recessive mutant genes predisposing to human cancer.
Mutation research 1986 Jul;168(1):3-14
-
Molecular genetics of human familial cancer.
Cold Spring Harbor symposia on quantitative biology 1986 Jan;51 Pt 2829-35
-
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition.
Proceedings of the National Academy of Sciences of the United States of America 1985 Sep;82(18):6216-20
-
Genetic origin of mutations predisposing to retinoblastoma.
Science (New York, N.Y.) 1985 Apr;228(4698):501-3
-
A Microdeletion Involving TNIK Alters the Phenotype in dup(3q) Syndrome
-
A previously unknown polymorphism located within the RB1 locus only present in Asian individuals.
Human heredity 46(2):118-20
-
Craniofacial Osteosarcomas Demonstrate Distinct Gene Expression Patterns Implicating Persistent Neural Crest Derived Stem Cells as the Cell of Origin
-
De novo germline mutations of the p53 gene in young children with sarcomas.
Oncology reports 4(4):679-83
-
Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.
Nature 309(5964):170-2
-
Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism.
Nature 316(6026):330-4
-
Receptor Activator of Nuclear Factor (NF)-kappa B (RANK) Signaling Regulates Osteoblast Migration
-
The Genetics of Retinoblastoma
Cancer Bulletin 46260-263
-
The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget’s Disease in the United States
J Rheumatol
Book Chapters
-
Expression Patterns of the Retinoblastoma Susceptibility Gene in Conventional and Variant Histology Osteosarcoma
Frontiers of Osteosarcoma Research 347-357
-
Genetics of Cancer Predisposition
Developmental Biology and Cancer 277-312
-
Genetics of Osteosarcoma
Topics in Bone Biology: Bone and Cancer 19-42
-
Loss of the Retinoblastoma Susceptibility Gene is Heterologous in Osteosarcoma
Current Communications in Molecular Biology: Recessive Oncogenes and Tumor Suppression 125-131
-
Osteosarcoma in Paget’s Disease of Bone
Paget’s Disease of Bone
-
Retinoblastoma Susceptibility, p53, and Other Tumor Suppressors
The Molecular Basis of Clinical Medicine 100-129
Conference Papers
-
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Nov;9(15):5442-53
-
Common mechanisms of osteosarcoma and Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999 Oct;14 Suppl 2(SUPPL. 2):39-44
Monographs
-
Molecular genetics and cytogenetics of sarcomas.
Hematology/oncology clinics of North America 1995 Jun;9(3):513-40
Newsletters
-
Functional Characterization of Inherited p53 Mutations
Cancer Bulletin 46247-253
-
Genetics of Familial Breast Cancer
Cancer Bulletin 45476-482
-
Molecular Genetics of Familial Colon Cancer
Cancer Bulletin 46315-321
-
Recessive Oncogenes in tTumorigenesis
Cancer Bulletin 4341-49
Reviews
-
Cancer stem cells and osteosarcoma: opportunities and limitations
Techniques in Orthopaedics 2019 Dec;34(4):275-286
-
Osteosarcoma in Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006 Dec;21 Suppl 2P58-63
-
Genetic and molecular aspects of osteosarcoma
Journal of Musculoskeletal Neuronal Interactions 2002 Jan;2(6):554-560